Futura Medical's development of a topical ... gel formulation achieved a significant improvement in erectile function compared to baseline at 24 weeks, across the range of mild, moderate and ...
The new topical agent — the anticholinergic sofpironium bromide gel — along with the targeted alkali thermolysis (TAT) patch approved in 2023 "may now be considered as first-line treatments ...
A study comparing a new topical gel formulation of oxybutynin to placebo has confirmed its efficacy and tolerability for treating overactive bladder. New formulations of oxybutynin have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results